For research use only. Not for therapeutic Use.
Memantine is a medication primarily used to treat moderate to severe Alzheimer’s disease. It works as an NMDA (N-methyl-D-aspartate) receptor antagonist, regulating the activity of glutamate, a neurotransmitter involved in learning and memory. By blocking excessive stimulation of NMDA receptors, Memantine helps protect neurons from excitotoxicity, a process that can lead to cell damage and death in neurodegenerative diseases. It is often prescribed to improve cognitive function, attention, and daily living activities in Alzheimer’s patients. Memantine is generally well-tolerated, with fewer side effects than other treatments, making it a valuable option for managing Alzheimer’s symptoms.
Catalog Number | M010406 |
CAS Number | 19982-08-2 |
Synonyms | 3,5-dimethyladamantan-1-amine; Namenda; 1-Amino-3,5-dimethyladamantane. |
Molecular Formula | C12H21N |
Purity | ≥95% |
Storage | Store at -20°C |
IUPAC Name | 3,5-dimethyladamantan-1-amine |
InChI | InChI=1S/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3 |
InChIKey | BUGYDGFZZOZRHP-UHFFFAOYSA-N |
SMILES | CC12CC3CC(C1)(CC(C3)(C2)N)C |